Cargando…
2394 Sodium-glucose transporter 2 is a novel diagnostic and therapeutic target for early-stage lung adenocarcinoma
OBJECTIVES/SPECIFIC AIMS: Lung cancer claims 160,000 lives in the United States every year, and lung adenocarcinoma (LADC) is the most frequent type. Early diagnosis is crucial. Computed tomography (CT) is very sensitive in identifying early-stage lung nodules, but has low specificity. Increased glu...
Autores principales: | Scafoglio, Claudio, Abdelhady, Gihad, Liu, Jie, Yanagawa, Jane, Wallace, Dean, Barrio, Jorge, Dubinett, Steven, Shackelford, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799059/ http://dx.doi.org/10.1017/cts.2018.122 |
Ejemplares similares
-
2543 High concentrations of CXCL12 decrease pancreatic adenocarcinoma growth
por: Vonderhaar, Emily, et al.
Publicado: (2018) -
2440 Teaching rigor, reproducibility, and transparency using gamification
por: Willig, James, et al.
Publicado: (2018) -
2235 15N-Leucine transport across the blood brain barrier is significantly impaired in the glutamine synthetase-inhibited brain
por: Gruenbaum, Shaun E., et al.
Publicado: (2018) -
2091 Neurophysiological substrates and developmental sequelae of sensory differences in infants at high risk for autism spectrum disorder
por: Woynaroski, Tiffany G., et al.
Publicado: (2018) -
3265 Analysis of High-Dimensional Patient Data in Characterizing Alzheimer’s Disease Progression
por: Baer, Daniel, et al.
Publicado: (2019)